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Abstract
Background: External quality assessments (EQA) are an alternative to cross-checking of blood slides in the quality
control of malaria microscopy. This study reports the findings of an EQA of malaria microscopy in the Democratic
Republic of the Congo (DRC).
Methods: After validation, an EQA slide panel and a questionnaire were delivered to diagnostic laboratories in four
provinces of DRC. The panel included three samples for diagnosis (sample 1: Plasmodium falciparum, 177,000/μl,
sample 2: P. falciparum, 2,500/μl, sample 3: no parasites seen), one didactic sample (Howell-Jolly bodies) and one
sample for assessing the quality of staining. Participating laboratories were addressed and selected through the
network of the National Tuberculosis Control Programme. Participants were asked to return the responses together
with a stained thin and thick blood film for evaluation of Giemsa stain quality.
Results: Among 174 participants (response rate 95.1%), 26.2% scored samples 1, 2 and 3 correctly and 34.3%,
21.5% and 5.8% of participants reported major errors in one, two or three samples respectively. Major errors
included reporting “no malaria” or “non-falciparum malaria” for Plasmodium falciparum-positive samples 1 and 2
(16.1% and 34.9% of participants respectively) and “P. falciparum“ for Plasmodium negative sample 3 (24.0%).
Howell-Jolly bodies (didactic sample) were not recognized by any of the participants but reported as “P.
falciparum“ by 16.7% of participants. With parasite density expressed according to the “plus system”, 16.1% and
21.5% of participants scored one “+” different from the reference score for samples 1 and 2 respectively and 9.7%
and 2.9% participants scored more than two “+” different. When expressed as counts of asexual parasites/μl, more
than two-thirds of results were outside the mean ± 2SD reference values. The quality of the Giemsa stain was
poor, with less than 20% slides complying with all criteria assessed. Only one quarter of participants purchase
Giemsa stain from suppliers of documented reliability and half of participants use a buffered staining solution. One
third of participants had participated in a formal training about malaria diagnosis, half of them earlier than 2007.
Conclusion: The present EQA revealed a poor quality of malaria microscopy in DRC.
Background
The detection of Plasmodium parasites by light micro-
scopy is still the primary method of malaria diagnosis in
most health care facilities throughout the world [1].
Quality control programmes are a prerequisite of com-
petent microscopy. The World Health Organization
(WHO) recommends the cross-checking of blood slides:
a sample of routine blood slides is sent to the reference
laboratory, where it is checked for accuracy. External
quality assessment (EQA) programmes (also referred to
as “proficiency testing”) are an alternative approach: in
such programmes, the reference laboratory sends stained
blood film samples to the peripheral laboratories, which
assess them and submit a report, after which they are
given feedback about the correct results and their own
performance [2].
I nt h eD e m o c r a t i cR e p u b l i co ft h eC o n g o( D R C ) ,
malaria is endemic and 97% of the population is living
in areas of stable malaria transmission. Parasite-based
diagnosis of malaria is mainly performed by microscopy.
Due to difficult economical and logistic conditions,
countrywide programmes of quality control of malaria
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grammes on malaria microscopy have been only spora-
dically organized and were limited to the capital
(Kinshasa) [3]. In 2010, the National Malaria Control
Programme (Programme National de la Lutte contre le
Paludisme, PLNP) organized an EQA session on malaria
microscopy through its national reference laboratory
(Institut National de Recherche Biomédicale, INRB) and
the network of laboratories participating in the national
programme of tuberculosis control (Programme
National de la Lutte contre la Tuberculose, PNLT). The
present study reports the results of this EQA session.
Methods
Participants
The EQA session was organized in 2010 and addressed
clinical laboratories subscribing to the EQA sessions on
parasitology of INRB as well as those involved in the net-
work of PNLT as deployed in four provinces: Kinshasa,
Bas- Congo, Katanga and the Oriental Province. In addi-
tion, the malaria reference laboratories at the provincial
level (n = 11) were included. Laboratories were categorized
as hospital-based (n = 72), referral health centre (n = 36),
health centre (n = 44) and others (n = 11). Table 1 gives
an overview of the participants who were located in areas
of hyper- of holo-endemic malaria transmission, with Plas-
modium falciparum accounting for more than 95% of
malaria infections.
Samples
The EQA panel consisted of five samples. Three samples
were prepared as Giemsa-stained thick and thin blood
film preparations with accompanying patient’sh i s t o r y
a n dw h i t eb l o o dc e l lc o u n t / μl (Table 2). Participants
were asked to report the diagnosis (malaria yes or no),
Plasmodium species identification and parasite density.
For parasite density, participants could express the value
as asexual parasites/μlo ra sa“plus system” scale (range
from “+” to “++++”) [4,5], as both systems were endorsed
by the national malaria control programme at the time of
EQA session. A fourth sample was a thin blood film with
red blood cells containing Howell-Jolly bodies, it was
considered as a didactic sample. A fifth sample consisted
of an unstained thin blood film: participants were asked
to stain this blood film according to their usual proce-
dure and return the sample. Finally, participants were
asked to select a routinely processed thick blood film
slide of their own laboratory and to return it together
with the fifth sample. Both samples were used to assess
the quality of the staining and thick blood film prepara-
tion as performed by the participants.
The samples were prepared from left-overs of routi-
nely drawn EDTA-blood samples obtained from patients
presenting at INRB and prepared and processed accord-
ing to the recommendations of PNLP and the WHO
malaria microscopy quality assurance manual [1,6].
Briefly, thin and thick blood films of each sample were
applied on a single slide (pre-cleaned slides, Menzel-
Gläzer Braunschweig, Germany). Fixation of thin blood
films was done with methanol (Panreac, Barcelona-
Spain), and thin and thick blood films were stained with
Giemsa pH 7.2 (MERCK, Darmstadt- Germany) and
examined by light microscopy using a × 1,000 magnifi-
cation. Parasite densities were estimated by counting
asexual parasites against 200 white blood cells in the
thick blood film and converting this number to para-
sites/μl using the actual white blood cell count as calcu-
lated microscopically in a Neubauer chamber [7]. To
compensate for technical and observational variations in
the parasite count, three expert microscopists counted
the parasite densities on 10 slides for each Plasmodium-
positive sample, and mean ± SD counts were calculated.
In addition, parasite densities were assessed according
to the “plus system”, i.e. a semi-quantitative scale esti-
mating the numbers of asexual parasites per high-power
fields [5]. Species identification was confirmed by Plas-
modium-specific polymerase chain reaction (PCR) [8,9].
Stained samples were allowed to dry, packed in plastic
boxes and stored for a maximum of 90 days before
shipment.
Table 1 Diagnostic laboratories participating in the EQA session on malaria microscopy
Provinces Estimated % nationwide coverage
Participants Bas-Congo Kinshasa Province Orientale Katanga Total
Provincial Reference Laboratories 1 1 1 1 11* 100,0
Hospitals 24 32 4 12 72 9.9
Referral Health Centres 22 11 0 3 36 1.0**
Health Centres 6 1 32 5 44
Private Laboratories 0 10 0 1 11 N.D.
Total 53 55 37 22 174 1.9
* Including the Provincial Reference Laboratories of the other seven provinces in DRC
** Combined on a total of 8,266 centres
N.D. = no data
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In addition to the samples, a questionnaire was sub-
mitted. The questionnaire addressed the following
issues: numbers of requests for malaria diagnosis, slide
positive ratio, staining procedures and training. In addi-
tion, participants were surveyed about the use of malaria
rapid diagnostic tests (RDTs).
Shipments
Samples and questionnaire were packed in plastic slide
boxes (Slide mailer, Menzel-Gläser, Braunschweig, Ger-
many) and shipped in protected envelopes (Air Pro 4,
Propac, Malmo, Sweden) according to UN 3373 recom-
mendations (i). For Kinshasa province, envelopes were
transported and on-site delivered by car by an INRB
collaborator. Samples for the provinces were shipped by
private air carrier to the provincial airports (Kisangani,
Lubumbashi and Boma/Kimpese in Oriental Province,
Katanga and Bas-Congo respectively) where they were
received by the provincial coordinators of PNLT or their
representatives. Next, they were transported by car and
hand-delivered to the participating laboratories. The
results and questionnaire forms, as well as the slides of
samples 5 and 6 were collected again by the PNLT
representative and shipped to INRB.
Validation of samples and questionnaire
For validation of the samples, shipment and question-
naire, a pilot EQA session was organized among 20
laboratories of known reputation (ten in Kinshasa, four
in Bas-Congo, and three in Katanga and Oriental Pro-
vince each). These 20 participants were actively surveyed
about the quality of the samples, instructions and sur-
vey. Their results were included in the analysis.
Data entry and analysis
The results were entered in an Excel database (Micro-
soft Corporation, Redmond, Washington, USA).
In diagnostic practice in DRC, parasite densities are
generally expressed according to the “plus system":
therefore, answers in terms of this score were primarily
considered. In addition, values expressed as asexual
parasites/μl were categorized in comparaison to the
mean reference count ± SD [10]. For evaluation of the
quality of staining and sample preparations (Samples 5
and 6), returned samples were assessed by two micro-
scopists and scored according to criteria from previous
studies and WHO recommendations (Table 3) [1,11,12].
Discordant results were assessed by a third observer and
the consensus result was considered.
Continuous variables were assessed for significance
using the Student’s t-test. Differences between propor-
tions were tested for significance using the Pearson’s
Chi-square test or, in case of small sample sizes, a two-
tailed Fisher’s exact test. Trends in proportions were
assessed using Chi-square test for trend.
The results for the microscopic diagnosis (samples 1, 2
and 3) were categorized as correct, or with minor and
major errors. Major errors included (i) incorrect diagnosis
of malaria, i.e.r e p o r t i n g“negative” in the case of a Plasmo-
dium-positive sample and vice versa, (ii) not mentioning
the presence of P. falciparum (either reporting non-falci-
parum species in the case of Plasmodium falciparum or
no species identification at all) and (iii) parasite densities
scored more than two “+” different from the reference
result or not scored at all. A minor error was defined as a
parasite density differing one “+” from the reference result.
Results
EQA sessions
The pilot EQA session was performed between August
and September 2010, the regular EQA session was per-
formed during the period September-November 2010.
Results of 174 out of 183 laboratories were received, with
a response rate of 95.1%. Median duration of shipment
from INRB to participants was 9 days (range 1 - 67 days),
Table 2 Clinical information, Plasmodium species and parasite density of the samples submitted as part of the EQA
session
Sample Sample information Reference result/Comment
1. Thick + thin blood film,
Giemsa stained
Girl 9 years old, fever, pale, weakness, Leukocyte count
10,400/μl
Plasmodium falciparum, parasite density 177,000/μlo r
“++++”
2. Thick + thin blood film,
Giemsa stained
Woman 54 years old, headache and fever, Leukocyte count
2,500/μl
Plasmodium falciparum, parasite density 86/μlo r“+”
3. Thick + thin blood film,
Giemsa stained
Man 57 years old, check-up visit No parasites seen
4. Thin blood film, Giemsa
stained
Woman, 39 years old, no clinical information No parasites seen, presence of Howell-Jolly bodies
5. Thin blood film,
unstained
Man, 36 years old, no clinical information Sample to be stained by the participants and returned
for scoring of staining quality
6. No sample Stained thick blood film sample to be selected from
routine samples by the participant
Sample to be sent to the reference lab for scoring of
staining quality
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days (range 1 - 25 days).
Results for the microscopic analysis of the samples
Tables 4, 5 and 6 present the results for samples 1, 2 and
3 respectively. For sample 1 (P. falciparum, 177.000/μl)
59.2% of participants scored correct results and another
16.1% reported minor errors, all but one were errors in
parasite density (reporting “+++” instead of the expected
“++++” score, 17.8%). Nearly a quarter (n = 43, 24.7%) of
participants reported major errors, these errors included
(i) reporting “no malaria” (5.2% of participants), (ii) “non-
falciparum malaria” (9.8%), and (iii) “+” or “++"or no
parasite density at all (8.6%); two participants (1.1%)
combined the latter two errors. Sample 2 (P. falciparum,
86/μl) was scored correct by less than half (41.9%) of par-
ticipants: 37 (21.5%) participants reported minor errors,
all but one scoring “++” for parasite density instead of
the expected “+”. Sixty-three (36.6%) of participants
reported major errors including (i) “no malaria” (16.3%),
(ii) “non-falciparum malaria” (18.6%), and parasite densi-
ties above “++” (2.9%). Two-thirds of participants scored
sample 3 (no parasites observed) correct. Major errors
among the remaining third included reporting of P. falci-
parum malaria (24.10%) with 9 (5.2%) of participants
reporting parasite densities above “+”. None of the parti-
cipants mentioned the presence of Howell-Jolly bodies in
sample 4. By contrast, for this parasite-negative sample,
24 (16.7%) of participants reported the presence of Plas-
modium parasites, mostly P. falciparum.
Among the participants who had valid answers for all
three samples (n = 172), 26.2% scored all three correctly;
34.3%, 21.5% and 5.8% had major errors for one, two
and all three samples respectively.
Parasite density expressed as parasites/μl
In addition to their report expressed as “plus system”,4 4
and 41 participants reported parasite densities as
Table 3 Results for the quality of staining of thin and thick blood film samples stained by the participants
Sample Criteria Numbers
(%)
Sample 5: Thin blood film supplied by EQA, stained by participant and returned to the reference
laboratory (n = 163)
No Giemsa stain precipitates
observed
107 (65.6%)
Red blood cells stained grey-pink 147 (90.2%)
Chromatin of lymphocytes stained
purple
60 (36.8%)
Granules of neutrophils stained
pink
100 (61.4%)
Complies with all criteria
mentioned above
16 (9.8%)
Sample 6: Routinely stained thick blood film of the participant submitted to the reference
laboratory (n = 155)
Correct dimensions (> 1 cm) and
thickness of the film
110 (71.0%)
Complete hemolysis of the red
blood cells
118 (76.1%)
No Giemsa stain precipitates
observed
60 (38.7%)
Good contrast between nucleus
and cytoplasm
70 (45.1%)
Complies with all criteria
mentioned above
30 (19.4%)
Table 4 Results for sample 1: P.falciparum, parasite density 177.000/μlo r“++++”. Valid answers of 174 participants
were included
Parasite density ("plus system”) Total
Reported result No parasites observed Not reported + ++ +++ ++++ n (%)
P. falciparum 1 5 9 27** 103* 145 (83.3%)
P. falciparum and P. malariae 1** 1 (0.6%)
P. malariae 1 1 2 4 (2.3%)
No species identification reported 1 3 11 15 (8.6%)
No parasites observed 9 9 (5.2%)
Total 9 2 5 10 31 116 174 (100%)
*Correct result, including one result reported as “+++++”
**Minor error
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respectively. Figures 1 and 2 display the distribution of
the parasite densities with respect to the mean ± SD
reference values. For sample 1, reported parasite densi-
ties ranged between 32 and 2,700,000/μl. Thirty-two
(72.7%) participants reported a parasite density > 2 SD
above or below the reference value, with 22 (49.9%) and
1 (2.3%) participants reporting a value 10 times higher
or lower the mean reference value. For sample 2, these
numbers were 32 (78.1%), 2 (4.9%), 16 (39.0%) respec-
tively, and parasite densities ranged between 1 and
32.000/μl.
Quality of Giemsa staining as scored on thin and thick
blood film preparations
Table 3 lists the scores for the quality of the Giemsa
staining for sample 5 (thin blood film supplied by EQA)
and sample 6 (thick blood film from the participants’
routine diagnosis). Although some scores for the indivi-
dual criteria were high, the overall quality was modest,
with only a minority (< 20%) of returned slides comply-
ing with all criteria assessed.
Results of the questionnaire
One third (32.7%) of participants had processed less
than 100 samples during the month before the EQA
and 58.3% had processed less than 200 samples. A total
of 25 (14.9%) of participants reported a slide positivity
ratio below 20%, whereas two-thirds (66.0%) declared
slide positivity ratios ≥ 40%, among which 26 (15.5%) ≥
80% (Figure 3).
Nearly two-thirds (63.8%) of participants had never
participated in a formal training on malaria microscopy,
and among those who did, more than half were trained
earlier than 2007. The situation was worst for the health
centres and reference health centres (no training for
69.8% and 75.0% of them repectively) than for the Pro-
vincial Reference Laboratories and referral hospitals (no
training for 45.5% and 52.5% of them respectively) but
this difference was not statistically significant (p =
0.136).
Participants were asked about their supply for Giemsa
stain and the use of buffer solution. The vast majority
(87.9%) purchased Giemsa stain as a stock solution. As to
the choice of supplier, only one quarter (25.3%) of parti-
cipants procured it from suppliers of documented relia-
bility like central purchasing services, non-governmental
organizations and the national malaria control pro-
gramme, while one third (35.6%) relied on “fournisseurs
ambulants”, i.e. private vendors who visit and deliver on
site. This reliance was more apparent among the refer-
ence health centres (22/36, 61.1%). For preparation of the
working solution, half (52.3%) of participants used a buf-
fer solution, 29.9% and 17.8% used distilled water and
regular water (mostly tap water) respectively. One quar-
ter (24.7%) of participants used RDTs, half of them since
one year or less. The majority (35, 81.4%) used Paracheck
(Orchid Biomedical Systems, Goa, India).
Table 5 Results for sample 2: P.falciparum, parasite density 86/μlo r“+”. Valid answers of 172 participants were
included
Parasite density (“plus system”) Total
Reported result No parasites observed Not reported + ++ +++ n (%)
P. falciparum 2 72* 36** 3 113 (65.7%)
P. vivax and P. falciparum 1** 1 (0.6%)
No species identification reported 27 5 32 (18.6%)
No parasites observed 26 26 (15.1%)
Total 28 2 100 41 3 172 (100.0%)
*Correct result
**Minor error
Table 6 Results for sample 3: No parasites observed
Parasite density (“plus system”) Total
Reported result No parasites observed Not reported + ++ +++ ++++ n (%)
No parasites observed 116* 116 (66.6%)
P. falciparum 1 35 4 1 41 (23.6%)
No species identification reported 1 11 2 1 1 16 (9.2%)
P. falciparum, gametocytes 1 1 (0.6%)
Total 116 3 46 6 2 1 174 (100.0%)
Valid answers of 174 participants included
*Correct result
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parameters
EQA performances in terms of correctness of answers
for the three diagnostic samples correlated with the
numbers of samples processed monthly (p < 0.001,
Figure 4) but not with other factors such as province,
training during the previous years or quality and origin
of the Giemsa stain. In addition, there was a tendency
towards better results related to hierarchy of structure,
with 16.3% of health centres, 20.0% of reference health
centres, 34.7% of hospitals and 45.5% of provincial
laboratories replying correct results for all three samples
(p = 0.064).
Discussion
Among 174 diagnostic laboratories in DRC participating
on an EQA session on malaria microscopy, 26.2% scored
all three samples correctly and 34.3%, 21.5% and 5.8%
reported major errors in one, two or all three samples
respectively. Major errors included missing the diagnosis
of P. falciparum malaria and diagnosis of malaria in
negative samples as well as errors in estimation of para-
site density. Most participants had serious problems for
the purchase and the preparation of the Giemsa stain
solution and two-thirds were not formally trained in
malaria microscopy.
Errors in diagnosis: false negative and false positive
results
Major errors included reports of “no malaria” or “non-falci-
parum malaria” in the case of P. falciparum-positive sam-
ples (16.1% and 34.9% for samples 1 and 2 respectively):
such false negative results may cause potentially lethal con-
sequences and erode confidence of clinicians and commu-
nity. Identification up to the level of P. falciparum has
been noted as a difficulty in non-endemic settings too: a
EQA session in Canada in 1995 recorded 27% errors in the
species diagnosis of P. falciparum, and 21% failures were
registered at an EQA session in the UK [12,13]. Further,
24.0% and 16.7% of participants in the present survey
reported “P. falciparum“ in the parasite negative samples 3
and 4 respectively: these false positive results lead to unne-
cessary treatment adding to costs side effects and distract
the clinician from considering other causes of fever and
disease. For comparison, EQA sessions in non-endemic
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ticipants and, in line with present observations, Howell-
Jolly bodies, fibrin strands and stain granules were con-
fused with blood parasites [13,14].
Errors in estimation of parasite densities
With parasite density expressed according to the “plus
system”, about 20% and 10% of participants scored one
“+” or ≥ “++” different from the reference value (consid-
ered as minor and major errors respectively). The quan-
tification according to the “+” scale is subject to
inconsistencies and WHO recommends it gradually
replacement by counts of asexual parasites/μl. The latter
system has only been introduced by PNLP since Octo-
ber 2010, which may explain in part for the poor results
presently observed. However, the high numbers of
apparent failures (> 10 × above or below the reference
value) illustrates the need for clear procedures, training
and follow-up during future EQA sessions [10]. Estima-
tion of parasite densities has been revealed as proble-
matic in several EQA sessions in non-endemic settings,
with up to 39% failures [13,14].
Reliable purchase of Giemsa stain and buffer
The quality of the Giemsa stain was poor, with < 20% of
slides stained by the participants complying with all cri-
teria assessed. Only one quarter of participants pur-
chased Giemsa stain from traceable suppliers such as
central purchasing services and the PNLP, while one
third relied on private salespersons and only half of
them used a buffered solution for the Giemsa stain.
These observations may be explained by the difficult
economic and logistic situation in DRC. Purchase poli-
cies and supplier evaluations are part of all quality
assurance systems and essential when considering the
Giemsa stain, for which quality-controlled production
and pH monitoring are essential [4].
Training and critical volume
Only one third of participants had attended a formal train-
ing about malaria microscopy, half of them earlier than
2007. Although slightly better at the central and inter-
mediate levels, the situation was of concern too. Training
is essential for maintaining competency and commitment
of microscopists [4] and PNLP is actually developing train-
ings programmes. One third of participating laboratories
processed less than 100 samples monthly. In addition,
there was an association between correct scores for this
EQA and the numbers of samples processed monthly.
Although the numbers of laboratory staff involved in
malaria diagnosis was not accounted, this provides indirect
evidence towards the association between low exposure
and poorer performance. For microscopists - provided
correctly trained - the reading of at least 10 slides a month
is recommended by WHO in order to maintain compe-
tence [4]. Further, the slide positivity rate varied widely:
although till now this parameter was only used as in indir-
ect indicator for malaria transmission and not for labora-
tory quality assessment [15,16]. The value of the slide
positivity rate as an indicator of quality assurance may be
explored. For instance, slide positivity rates ≥ 80% even in
highly selected patients might be questioned for accuracy
[17].
Limitations and strengths of EQA sessions including the
present one
T h ep r e s e n tE Q As e s s i o nu n d o u b t e d l ys u f f e r e df r o m
limitations inherent to EQA methods: for instance,
results for samples and questionnaires may reflect theo-
retical competence and knowledge rather than day-to-
day performance [14]. A second limitation relates to the
coverage of this EQA as less than 10% of hospitals and
1% of the health centres nationwide were included.
Finally, the current participants probably represent the
better laboratories, as participation was voluntary and
directed to laboratories already involved in the EQA
network of the PNLT. Logistic difficulties - a known
limitation of EQA sessions in resource constrained set-
tings [18] were behind this selection and approach,
since transport infrastructures and internet communica-
tion in DRC are limited, and the actual number of parti-
cipants was only reached by joining the network of
PNLT with its regional collaborators.
As to their strengths, it should be noted that EQA ses-
sions particularly when considered in an educational and
non-punitive atmosphere offer a didactic stimulus and
boost self-confidence and trigger towards implementa-
tion of a quality system, as participation is required for
accrediting norms such as ISO 15189 for medical labora-
tories [2,19]. For the health authorities and control pro-
grammes in resource constrained settings, EQA sessions
may be the first or unique information about nationwide
laboratory performance, diagnostic practices and the
quality of reagents or diagnostic tests [18,20-22]. The
results of the present EQA provide benchmark informa-
tion: this allows to monitor the progress in diagnostic
performance through follow-up EQA sessions. In addi-
tion, EQA sessions are more cost-effective than cross-
checking of slides [18]. Finally, the actual collaboration
between the PNLP and PLNT is in line with the WHO
recommendation of integrating malaria microscopy qual-
ity assessment with that of other microscopically diag-
nosed diseases such as tuberculosis [23,24].
Place and role of malaria rapid diagnostic test,
integration in quality assurance
The present results are in line with observations about
inadequate quality of microscopy in field settings [25].
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microscopy quality assurance will probably be very high;
therefore one might tend to favor rolling out malaria
rapid diagnostic tests (RDTs) at all levels of health care.
Indeed, despite the fact that RDTs no give information
about parasite density and species identification, their
diagnostic accuracy in field settings may equal or exceed
that of microscopy [26,27] and it is obvious that they
are less demanding with regard training, equipment and
infrastructure. PNLP is deploying RDTs in DRC since
June 2010. As for malaria microscopy, malaria RDTs
however need to be deployed in a quality assured envir-
onment at all levels [28-34].
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